Relmada Therapeutics (RLMD)

Relmada Therapeutics (RLMD) – Corporate News

Jan 4, 2024 07:33 AM Relmada Therapeutics (RLMD) Provides Corporate Update
Sep 20, 2023 08:31 AM Relmada Therapeutics (RLMD) Announces Efficacy and Safety Results from the Phase 3 Long-Term Study of REL-1017 in Major Depressive Disorder
Mar 23, 2023 04:02 PM
Jan 12, 2023 08:01 AM
Jan 9, 2023 08:01 AM
Dec 7, 2022 04:07 PM
Oct 13, 2022 07:04 AM
Aug 9, 2022 08:31 AM
Apr 29, 2022 08:31 AM
Apr 7, 2022 05:16 PM
Feb 23, 2022 06:32 AM
Dec 22, 2021 09:02 AM
Dec 9, 2021 05:45 AM
Dec 8, 2021 04:19 PM
Oct 4, 2021 08:32 AM
Jul 27, 2021 07:35 AM
Jul 20, 2021 08:17 AM
May 12, 2021 04:33 PM
Apr 1, 2021 08:07 AM
Mar 23, 2021 04:24 PM
Dec 7, 2020 08:40 AM
Jun 23, 2020 08:34 AM
May 27, 2020 08:08 AM
Jan 10, 2020 08:08 AM
Dec 20, 2019 08:07 AM
Dec 4, 2019 05:41 AM
Oct 15, 2019 08:06 AM
Oct 19, 2016 08:31 AM